NetworkNewsBreaks – Great Basin Scientific, Inc. (GBSN) Commences Commercial Launch of Bordetella Direct Test in U.S.; Receives CE Marking in EU
Great Basin Scientific (OTCQB: GBSN) this morning said it is initiating the U.S. commercial launch of its Bordetella Direct Test. The company also said it has received CE Marking designation under the European Directive on In Vitro Diagnostic Medical Devices, marking the company’s sixth assay to receive CE Marking under the directive. The Bordetella Direct Test also increases the company’s commercially available assays in the U.S. to five. “The processes we put in place that resulted in a swift FDA clearance also supported our ability to quickly commercialize the Bordetella Direct Test, much to the relief of many of our…
